Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment

por McDowell, Anthony, Hill, Kristen S., McCorkle, Joseph Robert, Gorski, Justin, Zhang, Yilin, Salahudeen, Ameen A., Ueland, Fred, Kolesar, Jill M.
Publicado 2021

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling

por Baldwin, Lauren A., Hoff, John T., Lefringhouse, Jason, Zhang, Michael, Jia, Changhe, Liu, Zeyi, Erfani, Sonia, Jin, Hongyan, Xu, Mei, She, Qing-Bai, van Nagell, John R., Wang, Chi, Chen, Li, Plattner, Rina, Kaetzel, David M., Luo, Jia, Lu, Michael, West, Dava, Liu, Chunming, Ueland, Fred R., Drapkin, Ronny, Zhou, Binhua P., Yang, Xiuwei H.
Publicado 2014

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

por Monk, Bradley J., Parkinson, Christine, Lim, Myong Cheol, O'Malley, David M., Oaknin, Ana, Wilson, Michelle K., Coleman, Robert L., Lorusso, Domenica, Bessette, Paul, Ghamande, Sharad, Christopoulou, Athina, Provencher, Diane, Prendergast, Emily, Demirkiran, Fuat, Mikheeva, Olga, Yeku, Oladapo, Chudecka-Glaz, Anita, Schenker, Michael, Littell, Ramey D., Safra, Tamar, Chou, Hung-Hsueh, Morgan, Mark A., Drochýtek, Vít, Barlin, Joyce N., Van Gorp, Toon, Ueland, Fred, Lindahl, Gabriel, Anderson, Charles, Collins, Dearbhaile C., Moore, Kathleen, Marme, Frederik, Westin, Shannon N., McNeish, Iain A., Shih, Danny, Lin, Kevin K., Goble, Sandra, Hume, Stephanie, Fujiwara, Keiichi, Kristeleit, Rebecca S.
Publicado 2022